Li J, Gao X, Ortega J, Nazif T, Joss L, Bogyo M, Steven A C, Rechsteiner M
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84132-0001, USA.
EMBO J. 2001 Jul 2;20(13):3359-69. doi: 10.1093/emboj/20.13.3359.
11S REGs (PA28s) are multimeric rings that bind proteasomes and stimulate peptide hydrolysis. Whereas REGalpha activates proteasomal hydrolysis of peptides with hydrophobic, acidic or basic residues in the P1 position, REGgamma only activates cleavage after basic residues. We have isolated REGgamma mutants capable of activating the hydrolysis of fluorogenic peptides diagnostic for all three active proteasome beta subunits. The most robust REGgamma specificity mutants involve substitution of Glu or Asp for Lys188. REGgamma(K188E/D) variants are virtually identical to REGalpha in proteasome activation but assemble into less stable heptamers/hexamers. Based on the REGalpha crystal structure, Lys188 of REGgamma faces the aqueous channel through the heptamer, raising the possibility that REG channels function as substrate-selective gates. However, covalent modification of proteasome chymotrypsin-like subunits by 125I-YL3-VS demonstrates that REGgamma(K188E)'s activation of all three proteasome active sites is not due to relaxed gating. We propose that decreased stability of REGgamma(K188E) heptamers allows them to change conformation upon proteasome binding, thus relieving inhibition of the CT and PGPH sites normally imposed by the wild-type REGgamma molecule.
11S调节因子(PA28)是与蛋白酶体结合并刺激肽水解的多聚体环。REGα激活蛋白酶体对P1位置带有疏水、酸性或碱性残基的肽的水解,而REGγ仅激活碱性残基后的切割。我们分离出了能够激活对所有三种活性蛋白酶体β亚基具有诊断作用的荧光肽水解的REGγ突变体。最有效的REGγ特异性突变体涉及用Glu或Asp取代Lys188。REGγ(K188E/D)变体在蛋白酶体激活方面与REGα几乎相同,但组装成的七聚体/六聚体稳定性较低。基于REGα晶体结构,REGγ的Lys188面向穿过七聚体的水通道,这增加了REG通道作为底物选择性门控发挥作用的可能性。然而,125I-YL3-VS对蛋白酶体胰凝乳蛋白酶样亚基的共价修饰表明,REGγ(K188E)对所有三个蛋白酶体活性位点的激活并非由于门控松弛。我们提出,REGγ(K188E)七聚体稳定性的降低使其在与蛋白酶体结合时能够改变构象,从而解除野生型REGγ分子通常对CT和PGPH位点的抑制。